仮想臨床試験の世界市場（～2026年）

• 英文タイトル：Global Virtual Clinical Trials Market Size, Status and Forecast 2020-2026

• レポートコード：MRC2-11QY05036 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,170,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は仮想臨床試験のグローバル市場について調査・分析したレポートです。種類別（介入試験、観察試験、拡張アクセス試験）市場規模、用途別（腫瘍、循環器疾患、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別仮想臨床試験の競争状況、市場シェア ・世界の仮想臨床試験市場：種類別市場規模 2015年-2020年（介入試験、観察試験、拡張アクセス試験） ・世界の仮想臨床試験市場：種類別市場規模予測 2021年-2026年（介入試験、観察試験、拡張アクセス試験） ・世界の仮想臨床試験市場：用途別市場規模 2015年-2020年（腫瘍、循環器疾患、その他） ・世界の仮想臨床試験市場：用途別市場規模予測 2021年-2026年（腫瘍、循環器疾患、その他） ・北米の仮想臨床試験市場分析：米国、カナダ ・ヨーロッパの仮想臨床試験市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの仮想臨床試験市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の仮想臨床試験市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの仮想臨床試験市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：ICON Plc、LEO Innovation Lab、Science 37、PRA Health Sciences、Clinical Ink、Parexel、Medable、Oracle、CRF Health、Medidata、Covance、IQVIA ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Virtual Clinical Trials (VCTs), also called remote or decentralized trials, are a relatively new and yet underutilized method of conducting clinical research taking full advantage of technologies such as apps, electronic monitoring devices, and online social engagement platforms.
Virtual clinical trials (VCT) eliminate challenges posed by traditional clinical trials such as time-consuming procedures and delay in patient recruitment that has driven the demand for the virtual clinical trial market. Moreover, technological advancements in healthcare infrastructure and alliances between biotechnology, pharmaceutical & clinical research organization are anticipated to boost the virtual clinical trials market growth in the near future.

Market Analysis and Insights: Global Virtual Clinical Trials Market
The global Virtual Clinical Trials market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Virtual Clinical Trials market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Virtual Clinical Trials market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Virtual Clinical Trials market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Virtual Clinical Trials market.

Global Virtual Clinical Trials Scope and Market Size
Virtual Clinical Trials market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Virtual Clinical Trials market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
Interventional Trials
Observational Trials
Expanded Access Trials

Market segment by Application, split into
Oncology
Cardiovascular Disease
Others

Based on regional and country-level analysis, the Virtual Clinical Trials market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Virtual Clinical Trials market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
ICON Plc
LEO Innovation Lab
Science 37
PRA Health Sciences
Clinical Ink
Parexel
Medable
Oracle
CRF Health
Medidata

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Virtual Clinical Trials Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Interventional Trials
1.2.3 Observational Trials
1.2.4 Expanded Access Trials
1.3 Market by Application
1.3.1 Global Virtual Clinical Trials Market Share by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiovascular Disease
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Virtual Clinical Trials Market Perspective (2015-2026)
2.2 Global Virtual Clinical Trials Growth Trends by Regions
2.2.1 Virtual Clinical Trials Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Virtual Clinical Trials Historic Market Share by Regions (2015-2020)
2.2.3 Virtual Clinical Trials Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Virtual Clinical Trials Players by Market Size
3.1.1 Global Top Virtual Clinical Trials Players by Revenue (2015-2020)
3.1.2 Global Virtual Clinical Trials Revenue Market Share by Players (2015-2020)
3.2 Global Virtual Clinical Trials Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Virtual Clinical Trials Revenue
3.4 Global Virtual Clinical Trials Market Concentration Ratio
3.4.1 Global Virtual Clinical Trials Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Virtual Clinical Trials Revenue in 2019
3.5 Key Players Virtual Clinical Trials Area Served
3.6 Key Players Virtual Clinical Trials Product Solution and Service
3.7 Date of Enter into Virtual Clinical Trials Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Virtual Clinical Trials Breakdown Data by Type (2015-2026)
4.1 Global Virtual Clinical Trials Historic Market Size by Type (2015-2020)
4.2 Global Virtual Clinical Trials Forecasted Market Size by Type (2021-2026)

5 Virtual Clinical Trials Breakdown Data by Application (2015-2026)
5.1 Global Virtual Clinical Trials Historic Market Size by Application (2015-2020)
5.2 Global Virtual Clinical Trials Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Virtual Clinical Trials Market Size (2015-2026)
6.2 North America Virtual Clinical Trials Market Size by Type (2015-2020)
6.3 North America Virtual Clinical Trials Market Size by Application (2015-2020)
6.4 North America Virtual Clinical Trials Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Virtual Clinical Trials Market Size (2015-2026)
7.2 Europe Virtual Clinical Trials Market Size by Type (2015-2020)
7.3 Europe Virtual Clinical Trials Market Size by Application (2015-2020)
7.4 Europe Virtual Clinical Trials Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Virtual Clinical Trials Market Size (2015-2026)
8.2 China Virtual Clinical Trials Market Size by Type (2015-2020)
8.3 China Virtual Clinical Trials Market Size by Application (2015-2020)
8.4 China Virtual Clinical Trials Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Virtual Clinical Trials Market Size (2015-2026)
9.2 Japan Virtual Clinical Trials Market Size by Type (2015-2020)
9.3 Japan Virtual Clinical Trials Market Size by Application (2015-2020)
9.4 Japan Virtual Clinical Trials Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Virtual Clinical Trials Market Size (2015-2026)
10.2 Southeast Asia Virtual Clinical Trials Market Size by Type (2015-2020)
10.3 Southeast Asia Virtual Clinical Trials Market Size by Application (2015-2020)
10.4 Southeast Asia Virtual Clinical Trials Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 ICON Plc
11.1.1 ICON Plc Company Details
11.1.2 ICON Plc Business Overview
11.1.3 ICON Plc Virtual Clinical Trials Introduction
11.1.4 ICON Plc Revenue in Virtual Clinical Trials Business (2015-2020))
11.1.5 ICON Plc Recent Development
11.2 LEO Innovation Lab
11.2.1 LEO Innovation Lab Company Details
11.2.2 LEO Innovation Lab Business Overview
11.2.3 LEO Innovation Lab Virtual Clinical Trials Introduction
11.2.4 LEO Innovation Lab Revenue in Virtual Clinical Trials Business (2015-2020)
11.2.5 LEO Innovation Lab Recent Development
11.3 Science 37
11.3.1 Science 37 Company Details
11.3.2 Science 37 Business Overview
11.3.3 Science 37 Virtual Clinical Trials Introduction
11.3.4 Science 37 Revenue in Virtual Clinical Trials Business (2015-2020)
11.3.5 Science 37 Recent Development
11.4 PRA Health Sciences
11.4.1 PRA Health Sciences Company Details
11.4.2 PRA Health Sciences Business Overview
11.4.3 PRA Health Sciences Virtual Clinical Trials Introduction
11.4.4 PRA Health Sciences Revenue in Virtual Clinical Trials Business (2015-2020)
11.4.5 PRA Health Sciences Recent Development
11.5 Clinical Ink
11.5.1 Clinical Ink Company Details
11.5.2 Clinical Ink Business Overview
11.5.3 Clinical Ink Virtual Clinical Trials Introduction
11.5.4 Clinical Ink Revenue in Virtual Clinical Trials Business (2015-2020)
11.5.5 Clinical Ink Recent Development
11.6 Parexel
11.6.1 Parexel Company Details
11.6.2 Parexel Business Overview
11.6.3 Parexel Virtual Clinical Trials Introduction
11.6.4 Parexel Revenue in Virtual Clinical Trials Business (2015-2020)
11.6.5 Parexel Recent Development
11.7 Medable
11.7.1 Medable Company Details
11.7.2 Medable Business Overview
11.7.3 Medable Virtual Clinical Trials Introduction
11.7.4 Medable Revenue in Virtual Clinical Trials Business (2015-2020)
11.7.5 Medable Recent Development
11.8 Oracle
11.8.1 Oracle Company Details
11.8.2 Oracle Business Overview
11.8.3 Oracle Virtual Clinical Trials Introduction
11.8.4 Oracle Revenue in Virtual Clinical Trials Business (2015-2020)
11.8.5 Oracle Recent Development
11.9 CRF Health
11.9.1 CRF Health Company Details
11.9.2 CRF Health Business Overview
11.9.3 CRF Health Virtual Clinical Trials Introduction
11.9.4 CRF Health Revenue in Virtual Clinical Trials Business (2015-2020)
11.9.5 CRF Health Recent Development
11.10 Medidata
11.10.1 Medidata Company Details
11.10.2 Medidata Business Overview
11.10.3 Medidata Virtual Clinical Trials Introduction
11.10.4 Medidata Revenue in Virtual Clinical Trials Business (2015-2020)
11.10.5 Medidata Recent Development
11.11 Covance
10.11.1 Covance Company Details
10.11.2 Covance Business Overview
10.11.3 Covance Virtual Clinical Trials Introduction
10.11.4 Covance Revenue in Virtual Clinical Trials Business (2015-2020)
10.11.5 Covance Recent Development
11.12 IQVIA
10.12.1 IQVIA Company Details
10.12.2 IQVIA Business Overview
10.12.3 IQVIA Virtual Clinical Trials Introduction
10.12.4 IQVIA Revenue in Virtual Clinical Trials Business (2015-2020)
10.12.5 IQVIA Recent Development

12Analyst’s Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Virtual Clinical Trials Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Interventional Trials
Table 4. Key Players of Observational Trials
Table 5. Key Players of Expanded Access Trials
Table 6. Global Virtual Clinical Trials Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 7. Global Virtual Clinical Trials Market Size by Regions (US$ Million): 2020 VS 2026
Table 8. Global Virtual Clinical Trials Market Size by Regions (2015-2020) (US$ Million)
Table 9. Global Virtual Clinical Trials Market Share by Regions (2015-2020)
Table 10. Global Virtual Clinical Trials Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 11. Global Virtual Clinical Trials Market Share by Regions (2021-2026)
Table 12. Virtual Clinical Trials Market Market Trends
Table 13. Virtual Clinical Trials Market Drivers
Table 14. Virtual Clinical Trials Market Challenges
Table 15. Virtual Clinical Trials Market Restraints
Table 16. Global Virtual Clinical Trials Revenue by Players (2015-2020) (US$ Million)
Table 17. Global Virtual Clinical Trials Market Share by Players (2015-2020)
Table 18. Global Top Virtual Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Virtual Clinical Trials as of 2019)
Table 19. Global Virtual Clinical Trials by Players Market Concentration Ratio (CR5 and HHI)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Virtual Clinical Trials Product Solution and Service
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Virtual Clinical Trials Market Size by Type (2015-2020) (US$ Million)
Table 24. Global Virtual Clinical Trials Market Size Share by Type (2015-2020)
Table 25. Global Virtual Clinical Trials Revenue Market Share by Type (2021-2026)
Table 26. Global Virtual Clinical Trials Market Size Share by Application (2015-2020)
Table 27. Global Virtual Clinical Trials Market Size by Application (2015-2020) (US$ Million)
Table 28. Global Virtual Clinical Trials Market Size Share by Application (2021-2026)
Table 29. North America Virtual Clinical Trials Market Size by Type (2015-2020) (US$ Million)
Table 30. North America Virtual Clinical Trials Market Share by Type (2015-2020)
Table 31. North America Virtual Clinical Trials Market Size by Application (2015-2020) (US$ Million)
Table 32. North America Virtual Clinical Trials Market Share by Application (2015-2020)
Table 33. North America Virtual Clinical Trials Market Size by Country (US$ Million) (2015-2020)
Table 34. North America Virtual Clinical Trials Market Share by Country (2015-2020)
Table 35. Europe Virtual Clinical Trials Market Size by Type (2015-2020) (US$ Million)
Table 36. Europe Virtual Clinical Trials Market Share by Type (2015-2020)
Table 37. Europe Virtual Clinical Trials Market Size by Application (2015-2020) (US$ Million)
Table 38. Europe Virtual Clinical Trials Market Share by Application (2015-2020)
Table 39. Europe Virtual Clinical Trials Market Size by Country (US$ Million) (2015-2020)
Table 40. Europe Virtual Clinical Trials Market Share by Country (2015-2020)
Table 41. China Virtual Clinical Trials Market Size by Type (2015-2020) (US$ Million)
Table 42. China Virtual Clinical Trials Market Share by Type (2015-2020)
Table 43. China Virtual Clinical Trials Market Size by Application (2015-2020) (US$ Million)
Table 44. China Virtual Clinical Trials Market Share by Application (2015-2020)
Table 45. China Virtual Clinical Trials Market Size by Region (US$ Million) (2015-2020)
Table 46. China Virtual Clinical Trials Market Share by Region (2015-2020)
Table 47. Japan Virtual Clinical Trials Market Size by Type (2015-2020) (US$ Million)
Table 48. Japan Virtual Clinical Trials Market Share by Type (2015-2020)
Table 49. Japan Virtual Clinical Trials Market Size by Application (2015-2020) (US$ Million)
Table 50. Japan Virtual Clinical Trials Market Share by Application (2015-2020)
Table 51. Japan Virtual Clinical Trials Market Size by Country (US$ Million) (2015-2020)
Table 52. Japan Virtual Clinical Trials Market Share by Country (2015-2020)
Table 53. Southeast Asia Virtual Clinical Trials Market Size by Type (2015-2020) (US$ Million)
Table 54. Southeast Asia Virtual Clinical Trials Market Share by Type (2015-2020)
Table 55. Southeast Asia Virtual Clinical Trials Market Size by Application (2015-2020) (US$ Million)
Table 56. Southeast Asia Virtual Clinical Trials Market Share by Application (2015-2020)
Table 57. Southeast Asia Virtual Clinical Trials Market Size by Country (US$ Million) (2015-2020)
Table 58. Southeast Asia Virtual Clinical Trials Market Share by Country (2015-2020)
Table 59. ICON Plc Company Details
Table 60. ICON Plc Business Overview
Table 61. ICON Plc Product
Table 62. ICON Plc Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 63. ICON Plc Recent Development
Table 64. LEO Innovation Lab Company Details
Table 65. LEO Innovation Lab Business Overview
Table 66. LEO Innovation Lab Product
Table 67. LEO Innovation Lab Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 68. LEO Innovation Lab Recent Development
Table 69. Science 37 Company Details
Table 70. Science 37 Business Overview
Table 71. Science 37 Product
Table 72. Science 37 Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 73. Science 37 Recent Development
Table 74. PRA Health Sciences Company Details
Table 75. PRA Health Sciences Business Overview
Table 76. PRA Health Sciences Product
Table 77. PRA Health Sciences Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 78. PRA Health Sciences Recent Development
Table 79. Clinical Ink Company Details
Table 80. Clinical Ink Business Overview
Table 81. Clinical Ink Product
Table 82. Clinical Ink Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 83. Clinical Ink Recent Development
Table 84. Parexel Company Details
Table 85. Parexel Business Overview
Table 86. Parexel Product
Table 87. Parexel Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 88. Parexel Recent Development
Table 89. Medable Company Details
Table 90. Medable Business Overview
Table 91. Medable Product
Table 92. Medable Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 93. Medable Recent Development
Table 94. Oracle Business Overview
Table 95. Oracle Product
Table 96. Oracle Company Details
Table 97. Oracle Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 98. Oracle Recent Development
Table 99. CRF Health Company Details
Table 100. CRF Health Business Overview
Table 101. CRF Health Product
Table 102. CRF Health Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 103. CRF Health Recent Development
Table 104. Medidata Company Details
Table 105. Medidata Business Overview
Table 106. Medidata Product
Table 107. Medidata Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 108. Medidata Recent Development
Table 109. Covance Company Details
Table 110. Covance Business Overview
Table 111. Covance Product
Table 112. Covance Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 113. Covance Recent Development
Table 114. IQVIA Company Details
Table 115. IQVIA Business Overview
Table 116. IQVIA Product
Table 117. IQVIA Revenue in Virtual Clinical Trials Business (2015-2020) (US$ Million)
Table 118. IQVIA Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Virtual Clinical Trials Market Share by Type: 2020 VS 2026
Figure 2. Interventional Trials Features
Figure 3. Observational Trials Features
Figure 4. Expanded Access Trials Features
Figure 5. Global Virtual Clinical Trials Market Share by Application: 2020 VS 2026
Figure 6. Oncology Case Studies
Figure 7. Cardiovascular Disease Case Studies
Figure 8. Others Case Studies
Figure 9. Virtual Clinical Trials Report Years Considered
Figure 10. Global Virtual Clinical Trials Market Size (US$ Million), YoY Growth 2015-2026
Figure 11. Global Virtual Clinical Trials Market Share by Regions: 2020 VS 2026
Figure 12. Global Virtual Clinical Trials Market Share by Regions (2021-2026)
Figure 13. Global Virtual Clinical Trials Market Share by Players in 2019
Figure 14. Global Top Virtual Clinical Trials Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Virtual Clinical Trials as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Virtual Clinical Trials Revenue in 2019
Figure 16. North America Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. United States Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Canada Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Europe Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. Germany Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. France Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. U.K. Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Italy Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Russia Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Nordic Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Rest of Europe Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Asia-Pacific Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. China Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Japan Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. South Korea Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Southeast Asia Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. India Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Australia Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Rest of Asia-Pacific Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Latin America Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Mexico Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Brazil Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Middle East & Africa Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Turkey Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Saudi Arabia Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. UAE Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Rest of Middle East & Africa Virtual Clinical Trials Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. ICON Plc Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 44. LEO Innovation Lab Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 45. Science 37 Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 46. PRA Health Sciences Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 47. Clinical Ink Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 48. Parexel Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 49. Medable Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 50. Oracle Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 51. CRF Health Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 52. Medidata Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 53. Covance Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 54. IQVIA Revenue Growth Rate in Virtual Clinical Trials Business (2015-2020)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed

---